In breast cancer, with regard to tumor expression of chemerin receptors, this adipokine is suggested to exert a tumor-suppressive role via binding to chemokine-like receptor 1 (CMKLR1) and G protein-coupled receptor 1 (GPR1) which effect growth-inhibitory downstream signaling [17]. Here, CMKLR2 is linked to breast cancer.